Caplin Point Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 234.40 | 214.60 | 214.86 |
| Operating Expense | 99.33 | 95.96 | 98.57 |
| Net Profit | 102.59 | 85.89 | 86.50 |
| Net Profit Margin | 43.77 | 40.02 | 40.26 |
| Earning Per Share | 13.50 | 11.30 | 11.37 |
| EBIDTA | 135.43 | 118.98 | 116.26 |
| Effective Tax Rate | 19.82 | 22.68 | 20.32 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 234.40 |
| Operating Expense | 99.33 |
| Net Profit | 102.59 |
| Net Profit Margin | 43.77 |
| Earning Per Share | 13.50 |
| EBIDTA | 135.43 |
| Effective Tax Rate | 19.82 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 752.41 | 625.09 | 528.61 |
| Operating Expenses Annual | 420.44 | 338.01 | 308.69 |
| Operating Profit Annual | 466.56 | 392.92 | 318.92 |
| Interest Annual | 0.12 | 0.10 | 0.12 |
| Depreciation | 23.69 | 25.96 | 24.38 |
| Net Profit Annual | 339.49 | 283.71 | 234.26 |
| Tax Annual | 102.18 | 82.03 | 58.89 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 752.41 |
| Operating Expenses Annual | 420.44 |
| Operating Profit Annual | 466.56 |
| Interest Annual | 0.12 |
| Depreciation | 23.69 |
| Net Profit Annual | 339.49 |
| Tax Annual | 102.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 80.64 | 122.02 | 81.01 |
| Cash Flow from Operations | 195.87 | 111.01 | 157.10 |
| Cash Flow from Investing | -138.77 | -118.13 | -85.67 |
| Cash Flow from Financing | -38.10 | -34.26 | -30.42 |
| Cash Flow at the End | 99.64 | 80.64 | 122.02 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 80.64 |
| Cash Flow from Operations | 195.87 |
| Cash Flow from Investing | -138.77 |
| Cash Flow from Financing | -38.10 |
| Cash Flow at the End | 99.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 62.01 | 62.86 | 60.33 |
| PBIT Margin (%) | 58.72 | 58.53 | 55.48 |
| PBT Margin (%) | -430.59 | -526.73 | -406.85 |
| Net PROFIT Margin (%) | 45.12 | 45.39 | 44.32 |
| Return On Networth / Equity (%) | 21.97 | 22.43 | 22.63 |
| Return On Networth /Employed (%) | 28.50 | 28.84 | 28.24 |
| Return On Assets (%) | 22.11 | 22.24 | 22.60 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.49 | 0.49 | 0.51 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 62.01 |
| PBIT Margin (%) | 58.72 |
| PBT Margin (%) | -430.59 |
| Net PROFIT Margin (%) | 45.12 |
| Return On Networth / Equity (%) | 21.97 |
| Return On Networth /Employed (%) | 28.50 |
| Return On Assets (%) | 22.11 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 205.26 | 165.79 | 156.85 |
| Total Current Assets Annual | 825.69 | 703.10 | 661.70 |
| Non Current Assets Annual | 988.79 | 819.21 | 641.48 |
| Total Shareholders Funds Annual | 1,700.93 | 1,390.15 | 1,139.91 |
| Total Assets Annual | 1,814.48 | 1,522.31 | 1,303.18 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 205.26 |
| Total Current Assets Annual | 825.69 |
| Non Current Assets Annual | 988.79 |
| Total Shareholders Funds Annual | 1,700.93 |
| Total Assets Annual | 1,814.48 |
EPS (INR)
Expected
20.57
Reported
20.32
Surprise
-1.22%
Jun 2025
EPS beaten by -1.22%
Mar 2025
EPS beaten by -0.05%
Dec 2024
EPS beaten by -0.05%
